您的位置: 首页 > 农业专利 > 详情页

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS
专利权人:
AGENSYS, INC.;SEATTLE GENETICS, INC.
发明人:
Robert Kendall MORRISON,Zili AN,Karen Jane Meyrick MORRISON,Josh SNYDER,Xiao-Chi JIA
申请号:
US15895996
公开号:
US20180251566A1
申请日:
2018.02.13
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充